These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20607755)

  • 1. Defining stage III disease in colorectal cancer--aspects on treatment and evaluation of survival.
    Derwinger K; Carlsson G; Ekman T
    J Surg Oncol; 2010 Oct; 102(5):424-7. PubMed ID: 20607755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of lymph node ratio in stage III colorectal cancer.
    Wong KP; Poon JT; Fan JK; Law WL
    Colorectal Dis; 2011 Oct; 13(10):1116-22. PubMed ID: 20874800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastatic lymph node size and colorectal cancer prognosis.
    Dhar DK; Yoshimura H; Kinukawa N; Maruyama R; Tachibana M; Kohno H; Kubota H; Nagasue N
    J Am Coll Surg; 2005 Jan; 200(1):20-8. PubMed ID: 15631916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should total number of lymph nodes be used as a quality of care measure for stage III colon cancer?
    Wang J; Kulaylat M; Rockette H; Hassett J; Rajput A; Dunn KB; Dayton M
    Ann Surg; 2009 Apr; 249(4):559-63. PubMed ID: 19300237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nodal stage of stage III colon cancer: the impact of metastatic lymph node ratio.
    Park IJ; Choi GS; Jun SH
    J Surg Oncol; 2009 Sep; 100(3):240-3. PubMed ID: 19330780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High epidermal growth factor receptor expression in metastatic colorectal cancer lymph nodes may be more prognostic of poor survival than in primary tumor.
    Deng Y; Kurland BF; Wang J; Bi J; Li W; Rao S; Lan P; Lin T; Lin E
    Am J Clin Oncol; 2009 Jun; 32(3):245-52. PubMed ID: 19451802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy.
    Kim YS; Kim JH; Yoon SM; Choi EK; Ahn SD; Lee SW; Kim JC; Yu CS; Kim HC; Kim TW; Chang HM
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):796-802. PubMed ID: 19289261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Impact of number of retrieved lymph nodes and lymph node ratio on the prognosis in patients with stage II and III colorectal cancer].
    Shao XL; Han HQ; He XL; Fu Q; Lv YC; Liu G
    Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Apr; 14(4):249-53. PubMed ID: 21538264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ratio of metastatic to resected lymph nodes enhances to predict survival in patients with stage III colorectal cancer.
    Qiu HB; Zhang LY; Li YF; Zhou ZW; Keshari RP; Xu RH
    Ann Surg Oncol; 2011 Jun; 18(6):1568-74. PubMed ID: 21207155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of lymph node ratio as a prognostic marker in colon cancer.
    Derwinger K; Carlsson G; Gustavsson B
    Eur J Surg Oncol; 2008 Jul; 34(7):771-5. PubMed ID: 18079086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The number of analyzed lymph nodes - a prognostic factor in colorectal cancer.
    Edler D; Ohrling K; Hallström M; Karlberg M; Ragnhammar P
    Acta Oncol; 2007; 46(7):975-81. PubMed ID: 17917828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis.
    Caplin S; Cerottini JP; Bosman FT; Constanda MT; Givel JC
    Cancer; 1998 Aug; 83(4):666-72. PubMed ID: 9708929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The metastatic lymph node ratio predicts survival in colon cancer.
    Schumacher P; Dineen S; Barnett C; Fleming J; Anthony T
    Am J Surg; 2007 Dec; 194(6):827-31; discussion 831-2. PubMed ID: 18005779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph node evaluation and long-term survival in Stage II and Stage III colon cancer: a national study.
    Vather R; Sammour T; Kahokehr A; Connolly AB; Hill AG
    Ann Surg Oncol; 2009 Mar; 16(3):585-93. PubMed ID: 19116751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymph node ratio: role in the staging of node-positive colon cancer.
    Wang J; Hassett JM; Dayton MT; Kulaylat MN
    Ann Surg Oncol; 2008 Jun; 15(6):1600-8. PubMed ID: 18327530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes.
    Berger AC; Sigurdson ER; LeVoyer T; Hanlon A; Mayer RJ; Macdonald JS; Catalano PJ; Haller DG
    J Clin Oncol; 2005 Dec; 23(34):8706-12. PubMed ID: 16314630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stage migration in colorectal cancer related to improved lymph node assessment.
    Derwinger K; Carlsson G; Gustavsson B
    Eur J Surg Oncol; 2007 Sep; 33(7):849-53. PubMed ID: 17379473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Metastatic lymph node ratio and outcome of surgical patients with stage III colorectal cancer].
    Liang J; Wei Y; Zhao C; Hong C
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Nov; 32(11):1663-6. PubMed ID: 23174600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinicopathological significance of inferior mesenteric lymph node metastasis in colorectal cancer.
    Kim JC; Lee KH; Yu CS; Kim HC; Kim JR; Chang HM; Kim JH; Kim JS; Kim TW
    Eur J Surg Oncol; 2004 Apr; 30(3):271-9. PubMed ID: 15028308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer.
    Sarli L; Bader G; Iusco D; Salvemini C; Mauro DD; Mazzeo A; Regina G; Roncoroni L
    Eur J Cancer; 2005 Jan; 41(2):272-9. PubMed ID: 15661553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.